Elastomeric Infusion Pumps Market Growth Drivers and Challenges:
Growth Drivers
- Demand for chronic disease management - The growth in chronic illnesses highlights the need for simple and efficient treatment options, which elastomeric infusion pumps might assist address. The need for long-term medication delivery solutions is growing as chronic diseases become more prevalent. Elastomeric pumps provide the efficient and comfortable administration of continuous medication delivery, enhancing patient adherence and quality of life.
They provide a useful alternative to traditional delivery methods, such as regular injections or oral medications, particularly for patients with conditions requiring ongoing treatment monitoring. Businesses are using cutting-edge technology to manage diseases. The FDA has approved Baxter International Inc.'s Novum IQ syringe infusion pump with Dose IQ Safety Software in the United States, according to the top inventor in medication delivery technology.
- Growing product development and innovation - Increasing product development and innovation within the market's key players, as well as an increasing number of elastomer infusion pumps in use, are contributing to this expansion. B. Braun, on the other hand, has developed a Space Pump+ Pro Infusion System that includes integrated intelligent features like automatic medication verification and monitoring over the Internet.
Challenges
- Limited drug compatibility - In the elastomeric infusion pumps business, limited compatibility with medicinal products presents a challenge, which could affect adoption and use rates. The restrictions to the supply of pharmaceuticals via elastomer pumps limit the potential market for these devices. This is because if healthcare professionals are unable to deliver the necessary medicines effectively, they may be reluctant to use these devices.
- The high cost of the elastomeric infusion pumps market is predicted to hinder growth in the upcoming period.
- Strict regulations associated with use are another notable factor hindering the market expansion in the future.
Elastomeric Infusion Pumps Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
7.2% |
|
Base Year Market Size (2025) |
USD 973.73 million |
|
Forecast Year Market Size (2035) |
USD 1.95 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of elastomeric infusion pumps is evaluated at USD 1.04 billion.
The global elastomeric infusion pumps market size was worth more than USD 973.73 million in 2025 and is poised to witness a CAGR of over 7.2%, crossing USD 1.95 billion revenue by 2035.
North America elastomeric infusion pumps market is poised to capture 40.8% share by 2035, driven by chronic disease prevalence and strong healthcare infrastructure.
Key players in the market include Ace-Medical, Avanos Medical, Inc., VYGON UK Ltd., Woo Young Medical Co., PROMECON GmbH, Baxter International Inc..
